Suraj Mudichintala

Suraj Mudichintala is a senior associate at APVC in Santa Cruz, CA. He represents APVC on the Boards of Alpheus Medical, Axon Therapies and Onc.ai.
He was previously an investor at Arboretum Ventures, where he served as a Board observer at Allay Therapeutics, Avation Medical, Francis Medical, Health Scholars, Koya Medical, and RareCyte.
Prior to investing, Suraj was an associate with L.E.K.
Consulting, a global strategy consulting firm.
While at L.E.K., Suraj completed ~20 engagements predominantly for life sciences and private equity clients.
Suraj graduated cum laude with a B.S.
in Finance and Analytics from Boston College.
Suraj previously served on the Michigan Translational Research and Commercialization (MTRAC) Oversight Committee for Medical Devices, where he provided guidance to Michigan higher education researchers on transitioning their early stage products to the private sector for commercialization.